{"schema_version":"secwatch.filing_event.v1","accession":"0001822359-24-000092","form_type":"8-K","ticker":"DCGO","cik":"0001822359","company_name":"DocGo Inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.836064+00:00","generated_at":"2026-05-30T03:46:58.465704+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"DocGo Q3 2024 revenue falls 26% to $138.7M; raises FY2024 cash flow guidance to $90-100M","bullets":["Q3 revenue $138.7M (-26% YoY) from migrant program wind down; net income $4.5M (flat YoY).","Adjusted EBITDA $17.9M (+7% YoY); adjusted gross margin improved to 36.0% from 29.5%.","FY2024 revenue guidance tightened to $620-630M; adj. EBITDA guided to $70-75M; cash flow ops raised to $90-100M.","FY2025 revenue expected $410-450M with adj. EBITDA margin of 8%-10%.","Care gap closure patients >500k; expanded West Coast operations; Dr. Stephen Klasko appointed board chair."],"urls":{"canonical":"https://secwatch.observer/filing/0001822359-24-000092","json":"https://secwatch.observer/filing/0001822359-24-000092.json","markdown":"https://secwatch.observer/filing/0001822359-24-000092.md","text":"https://secwatch.observer/filing/0001822359-24-000092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000092/0001822359-24-000092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822359/000182235924000092/dcgo-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:46:58.465704+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}